Correlation Between Assembly Biosciences and Spero Therapeutics

Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Spero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Spero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Assembly Biosciences and Spero Therapeutics, you can compare the effects of market volatilities on Assembly Biosciences and Spero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Spero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Spero Therapeutics.

Diversification Opportunities for Assembly Biosciences and Spero Therapeutics

0.85

Correlation Coefficient

Assembly Biosciences  Spero Therapeutics

Very poor diversification

The 3 months correlation between Assembly and Spero is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Spero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spero Therapeutics and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Spero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spero Therapeutics has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Spero Therapeutics go up and down completely randomly.

Pair Corralation between Assembly Biosciences and Spero Therapeutics

Given the investment horizon of 90 days Assembly Biosciences is expected to under-perform the Spero Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Assembly Biosciences is 1.18 times less risky than Spero Therapeutics. The stock trades about -0.17 of its potential returns per unit of risk. The Spero Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest  102.00  in Spero Therapeutics on December 29, 2024 and sell it today you would lose (16.00) from holding Spero Therapeutics or give up 15.69% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Assembly Biosciences  vs.  Spero Therapeutics

Assembly Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Assembly Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Spero Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spero Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Assembly Biosciences and Spero Therapeutics

The main advantage of trading using opposite Assembly Biosciences and Spero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Spero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spero Therapeutics will offset losses from the drop in Spero Therapeutics' long position.

The idea behind Assembly Biosciences and Spero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.